DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Tanigawa T, Kaneko M, Hashizume K , et al.
Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation.
Drug Metab Pharmacokinet 2013;
28 (1) 59-70
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.